U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07556848) titled 'A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer' on April 22.

Brief Summary: The purpose of this study is to compare the efficacy and safety of 9MW2821 versus investigator's choice of chemotherapy in participants with locally advanced or metastatic triple-negative breast cancer who have previously received taxane-based chemotherapy with or without immunotherapy and an antibody-drug conjugate with a topoisomerase inhibitor payload

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Locally Advanced or Metastatic Triple-negat...